We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AbbVie has settled its lawsuit with Boehringer Ingelheim, the last domino to fall in an all-out patent war that will protect AbbVie’s mega-blockbuster Humira until 2023. Read More
Merck urged the FDA to look into potential safety concerns as the agency seeks to widen patient eligibility criteria for oncology drug trials of HIV, hepatitis B and hepatitis C patients. Read More
Acting FDA Commissioner Ned Sharpless said the agency is inching closer to bringing cheaper insulins to the market but that critical regulatory questions remain. Read More
The guidance draws a line between information about patients’ health status or healthcare delivery “routinely collected from a variety of sources” and clinical evidence for a drug from analysis of real-world data. Read More
The acquisition is intended to shift the company from a traditional physician outreach model to a real-time approach that takes care of patient identification at the lab. Read More